Whitepaper

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities beyond the USA and Japan in 2023. With industries identifying new avenues to design the best market entry strategy strategies in 2023 for each market, it is important for them to conduct thorough research on respective regions or customs to make strategies based on geography.

Key Takeaways

  • Dollar fluctuations and the looming market recession have compelled investors and manufacturers of medical devices and pharma to explore new opportunities beyond the US and Japan.
  • By undertaking in-depth research, SG Analytics is assisting clients in tracking the markets based on their services and products. 
  • SGA's white-labeled and custom-built services make us the exclusive partner for our clients in the market entry in 2023.

To know more...


Related Topics

Corporate governance- ESG Whitepaper

White Papers

Corporate Governance: Cross-Shareholding and Its Impact on...

An essential facet of business operations, corporate governance has increasingly come under scrutiny for its pivotal role in shaping corporate behavior and...

Bio Diversity Whitepaper by SG Analytics

White Papers

Board Diversity and Its Influence on ESG Outcomes

In the contemporary corporate landscape, ESG factors have become integral to evaluating a company’s long-term sustainability and ethical impact. With...

Decoding ISSB- ESG Whitepaper

White Papers

Decoding ISSB

The International Sustainability Standards Board, or ISSB, aims to integrate various existing sustainability frameworks to create a unified set of standards...

VIEW MORE

We bring comprehensive data driven insights to everyone, everywhere